Market Overview:
The global VLP vaccines market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for preventive vaccines, and technological advancements in vaccine development. The HPV vaccine segment is expected to account for the largest share of the global VLP vaccines market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period. The growth in this segment can be attributed to rising awareness about HPV and its associated risks, growing demand for preventive vaccines, and technological advancements in vaccine development. The medical institution segment is expected to account for the largest share of the global VLP vaccines market by application in 2018.
Product Definition:
A VLP vaccine is a vaccine made from virus-like particles (VLPs). These are proteins that mimic the structure of viruses, but are not infectious. VLP vaccines can be produced without using live viruses, and so they are safer than traditional vaccines. They also provoke a stronger immune response.
HPV Vaccine:
Human Papillomavirus is a group of more than 100 related viruses. More than 90% of the cases are subtypes 16 and 18, which cause warts on the skin. The other subtypes include 6 & 11, 13, 31 & 33 and 45&51 that lead to various cancers in different parts of the body.
Covid-19 Vaccine:
Covid-19 vaccine is a new and innovative way of preventing infection. It is an injection that protects against Covid-19, the novel coronavirus. The vaccine was approved by the U.
Application Insights:
The government application segment led the global VLP vaccines market in 2017. The increasing prevalence of infectious diseases, particularly in developed countries such as the U.S., Canada, and France is expected to drive demand for immunization against these diseases in the near future. For instance, according to a study published by NCBI on April 26th 2018, it was found that about 10 million people were infected with hepatitis A virus and about 20 million were infected with hepatitis B virus globally every year till 2016. Therefore, an increase in incidence of infectious diseases will lead to an increased demand for immunization against them which is likely to propel growth over the forecast period.
Medical institutions are estimated to be one of the fastest-growing segments over the forecast period owing to increasing awareness regarding preventable infections among individuals undergoing medical procedures such as dialysis or blood transfusions across hospitals.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in research & development, and increasing demand for preventive healthcare. The U.S., which is at the forefront of this regional market, has witnessed significant growth with respect to immunization since HPV was introduced as a vaccine in 2006 followed by COVID-19 in 2018.
The Asia Pacific region is expected to witness lucrative growth over the forecast period owing to rising awareness about various vaccines among individuals and government bodies coupled with growing investments by international companies for manufacturing these vaccines at low costs thus making it accessible for more people thereby boosting its demand across this region (APAC). Covid-19 vials are being manufactured by two different manufacturers based out of India; however they have not yet started shipping them due to lack of resources such as technicians and skilled workers necessary for proper packaging resulting from which there will be no supply until further notice or until adequate resources are available.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the VLP vaccines market. Infectious diseases are caused by pathogenic microorganisms, which can spread from one person to another and cause serious health problems. The increasing incidence of such infections is driving the demand for effective and safe vaccines.
- Growing awareness about vaccination: There is a growing awareness among people about the importance of vaccination, which is driving the demand for VLP vaccines. Vaccination helps in preventing various life-threatening infections and helps in maintaining public health.
- Technological advancements in vaccine development: The technological advancements in vaccine development are helping to drive the growth of the VLP vaccines market. With continuous innovations taking place in this field, new and more effective vaccines are being developed, which is aiding in propelling this market forward.
Scope Of The Report
Report Attributes
Report Details
Report Title
VLP Vaccines Market Research Report
By Type
HPV Vaccine, Covid-19 Vaccine, Hepatitis B Vaccine, Others
By Application
Government, Medical Institution, Others
By Companies
Medicago, Novavax, Saiba Animal Health, VBI, ARTES Biotechnology, VLP Therapeutics, POSVAX, Spybiotech, Optipharm Co. Ltd, H&Z Life Science, Gproan, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global VLP Vaccines Market Report Segments:
The global VLP Vaccines market is segmented on the basis of:
Types
HPV Vaccine, Covid-19 Vaccine, Hepatitis B Vaccine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Government, Medical Institution, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medicago
- Novavax
- Saiba Animal Health
- VBI
- ARTES Biotechnology
- VLP Therapeutics
- POSVAX
- Spybiotech
- Optipharm Co. Ltd
- H&Z Life Science
- Gproan
- Merck
Highlights of The VLP Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HPV Vaccine
- Covid-19 Vaccine
- Hepatitis B Vaccine
- Others
- By Application:
- Government
- Medical Institution
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the VLP Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vaccines are a type of medication that help protect people from diseases. VLP vaccines are a type of vaccine that uses small pieces (VLPs) of the virus instead of whole viruses. This makes them easier to store and transport, which may make them more effective in preventing disease.
Some of the major players in the vlp vaccines market are Medicago, Novavax, Saiba Animal Health, VBI, ARTES Biotechnology, VLP Therapeutics, POSVAX, Spybiotech, Optipharm Co. Ltd, H&Z Life Science, Gproan, Merck.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 VLP Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 VLP Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 VLP Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the VLP Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global VLP Vaccines Market Size & Forecast, 2020-2028
4.5.1 VLP Vaccines Market Size and Y-o-Y Growth
4.5.2 VLP Vaccines Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 HPV Vaccine
5.2.2 Covid-19 Vaccine
5.2.3 Hepatitis B Vaccine
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Government
6.2.2 Medical Institution
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global VLP Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 VLP Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 HPV Vaccine
9.6.2 Covid-19 Vaccine
9.6.3 Hepatitis B Vaccine
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Government
9.10.2 Medical Institution
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 HPV Vaccine
10.6.2 Covid-19 Vaccine
10.6.3 Hepatitis B Vaccine
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Government
10.10.2 Medical Institution
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 HPV Vaccine
11.6.2 Covid-19 Vaccine
11.6.3 Hepatitis B Vaccine
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Government
11.10.2 Medical Institution
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 HPV Vaccine
12.6.2 Covid-19 Vaccine
12.6.3 Hepatitis B Vaccine
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Government
12.10.2 Medical Institution
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 HPV Vaccine
13.6.2 Covid-19 Vaccine
13.6.3 Hepatitis B Vaccine
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Government
13.10.2 Medical Institution
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 VLP Vaccines Market: Competitive Dashboard
14.2 Global VLP Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medicago
14.3.2 Novavax
14.3.3 Saiba Animal Health
14.3.4 VBI
14.3.5 ARTES Biotechnology
14.3.6 VLP Therapeutics
14.3.7 POSVAX
14.3.8 Spybiotech
14.3.9 Optipharm Co. Ltd
14.3.10 H&Z Life Science
14.3.11 Gproan
14.3.12 Merck
